The store will not work correctly when cookies are disabled.
JavaScript seems to be disabled in your browser. For the best experience on our site, be sure to turn on Javascript in your browser.
5-((4-chloro-2,5-dimethylphenylsulfinyl)methyl)-1H-pyrazol-3(2H)-one ID: ALA2165601
PubChem CID: 56945435
Max Phase: Preclinical
Molecular Formula: C12H13ClN2O2S
Molecular Weight: 284.77
Molecule Type: Small molecule
This compound is available for customization.
Associated Items:
Names and Identifiers Canonical SMILES: Cc1cc([S+]([O-])Cc2cc(=O)[nH][nH]2)c(C)cc1Cl
Standard InChI: InChI=1S/C12H13ClN2O2S/c1-7-4-11(8(2)3-10(7)13)18(17)6-9-5-12(16)15-14-9/h3-5H,6H2,1-2H3,(H2,14,15,16)
Standard InChI Key: LLYDYCITFBXENR-UHFFFAOYSA-N
Molfile:
RDKit 2D
18 19 0 0 0 0 0 0 0 0999 V2000
11.9080 -9.0667 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
11.9148 -9.8987 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
11.1989 -10.3187 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
10.4757 -9.9081 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
10.4729 -9.0729 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
11.1893 -8.6567 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
9.7531 -8.6605 0.0000 S 0 0 0 0 0 0 0 0 0 0 0 0
9.0360 -9.0774 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
9.7505 -7.8309 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
8.3163 -8.6649 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
7.5620 -9.0077 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
7.0050 -8.3929 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
7.4176 -7.6731 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
8.2295 -7.8432 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
7.0779 -6.9163 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
12.6365 -10.3079 0.0000 Cl 0 0 0 0 0 0 0 0 0 0 0 0
9.7595 -10.3267 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
12.6236 -8.6472 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
1 2 2 0
2 3 1 0
3 4 2 0
4 5 1 0
5 6 2 0
6 1 1 0
5 7 1 0
7 8 1 0
7 9 1 0
8 10 1 0
10 11 1 0
11 12 1 0
12 13 1 0
13 14 1 0
14 10 2 0
13 15 2 0
2 16 1 0
4 17 1 0
1 18 1 0
M CHG 2 7 1 9 -1
M END Associated Targets(Human) Molecule Features Natural Product: NoOral: NoChemical Probe: NoParenteral: NoMolecule Type: Small moleculeTopical: NoFirst In Class: NoBlack Box: NoChirality: NoAvailability: NoProdrug: No
Drug Indications MESH ID MESH Heading EFO IDs EFO Terms Max Phase for Indication References
Mechanisms of Action Mechanism of Action Action Type target ID Target Name Target Type Target Organism Binding Site Name References
Calculated Properties Molecular Weight: 284.77Molecular Weight (Monoisotopic): 284.0386AlogP: 2.28#Rotatable Bonds: 3Polar Surface Area: 71.71Molecular Species: NEUTRALHBA: 2HBD: 2#RO5 Violations: ┄HBA (Lipinski): 4HBD (Lipinski): 2#RO5 Violations (Lipinski): ┄CX Acidic pKa: 8.00CX Basic pKa: ┄CX LogP: 1.36CX LogD: 1.27Aromatic Rings: 2Heavy Atoms: 18QED Weighted: 0.85Np Likeness Score: -0.61
References 1. Chen T, Benmohamed R, Kim J, Smith K, Amante D, Morimoto RI, Kirsch DR, Ferrante RJ, Silverman RB.. (2012) ADME-guided design and synthesis of aryloxanyl pyrazolone derivatives to block mutant superoxide dismutase 1 (SOD1) cytotoxicity and protein aggregation: potential application for the treatment of amyotrophic lateral sclerosis., 55 (1): [PMID:22191331 ] [10.1021/jm2014277 ]